Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 503-508

  Solbu, Marit D ^a,d   Kronborg, Jens ^b,d   Jenssen, Trond G ^c,d   Njølstad, Inger ^d   Løchen, Maja Lisa ^a,d   Mathiesen, Ellisiv B ^a,d   Wilsgaard, Tom ^d   Eriksen, Bjørn O ^a,d   Toft, Ingrid ^a,d  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b INNLANDET HOSPITAL TRUST   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Albuminuria; All cause mortality; Cardiovascular risk; Epidemiology; Metabolic syndrome

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK ASSESSMENT;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 65649145291     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.11.002     Document Type: Article

References (30)

1. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S46-S76
2. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310 (1984) 356-360
3. Ljungman S., Wikstrand J., Hartford M., and Berglund G. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 9 (1996) 770-778
4. Arnlov J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112 (2005) 969-975
5. Jørgensen L., Jenssen T., Heuch I., and Jacobsen B.K. The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in non-diabetic persons. J Intern Med 264 (2008) 493-501
6. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
7. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
8. Gale E.A. The myth of the metabolic syndrome. Diabetologia 48 (2005) 1679-1683
9. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter?. Circulation 115 (2007) 1806-1811
10. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
11. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
12. Jager A., Kostense P.J., Nijpels G., et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 41 (1998) 694-700
13. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
14. Kronborg J., Solbu M., Njolstad I., et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant 23 (2008) 2818-2826
15. Levey A.S., Coresh J., Greene T., et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol 16 (2005) 69A [abstract]
16. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
17. WHO MONICA Project Principal Investigators. The world health organization monica project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41 (1988) 105-114
18. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003) 2543-2549
19. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
20. Klausen K.P., Parving H.H., Scharling H., and Jensen J.S. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 262 (2007) 470-478
21. Ingelsson E., Sullivan L.M., Murabito J.M., et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 56 (2007) 1718-1726
22. Solbu M.D., Kronborg J., Eriksen B.O., Jenssen T.G., and Toft I. Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study. Atherosclerosis 201 (2008) 398-406
23. National Cholesterol Education Program: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
24. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
25. Shlipak M.G., Katz R., Sarnak M.J., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
26. de Zeeuw D., Parving H.H., and Henning R.H. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 17 (2006) 2100-2105
27. Russo L.M., Comper W.D., and Osicka T.M. Mechanism of albuminuria associated with cardiovascular disease and kidney disease. Kidney Int Suppl (2004) S67-S68
28. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113 (2006) e873-e923
29. Cao J.J., Barzilay J.I., Peterson D., et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health Study. Atherosclerosis 187 (2006) 372-377
30. Holme I., Sogaard A.J., Haheim L.L., Larsen P.G.L., and Tonstad S. Repeated weight loss is associated with the metabolic syndrome and diabetes: results of a 28 year re-screening of men in the Oslo Study. Metab Syndrome Relat Disord 5 (2007) 127-135